Early win means phase 3 test is on the way for Axovant's dementia drug | FierceBiotech


Positive results in a first crop of patients treated with its dementia drug have encouraged Axovant to start preparing for a phase 3 study.
http://bit.ly/2l1LIPm

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s